BackMira Pharmaceuticals Overview

Mira Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for MIRA.

Quarterly EBIT

-$1.10M
38.87% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$1.84M
115.5% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)